Universitair Ziekenhuis Gent — Ghent

Public research footprint of Universitair Ziekenhuis Gent, compiled from the ClinicalTrials.gov public registry.

522

Registered studies

179

Active

Recruiting now

252

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Non-Small Cell Lung Cancer (NSCLC) · Clostridium Difficile Infection Recurrence · Clostridioides Difficile Infection Recurrence

Recently updated registry entries

NCT05531565 — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… (Active Not Recruiting)
NCT04640623 — A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… (Active Not Recruiting)
NCT04175600 — A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitair Ziekenhuis Gent?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.